Tris Pharma has set its sights on an FDA filing for pipeline drug cebranopadol before the end of this year after the drug achieved significant pain relief in abdominoplasty patients in a late ...

Nasdaq Listed Nasdaq 100 Alerts Market: Open Micron Technology, Inc. Common Stock (MU) Bid: $127.34 X 427 Ask: $127.36 X 600 Volume: 14,151,693 ...

After years in development, the FDA has started its review of Pfizer and Eli Lilly’s new painkiller tanezumab, one of two remaining drugs in the ill-fated nerve growth factor (NGF) inhibitor ...